Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

Seung Tae Kim, Răzvan Cristescu, Adam J. Bass, +20

Nature Medicine

Gastrointestinal OncologyPd-1 InhibitionMedicineComprehensive Molecular CharacterizationPharmacology +7

Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

Jung Hun Kang, Soon Il Lee, Do Hyoung Lim, +13

Journal of Clinical Oncology

Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses

Se Hoon Park, Tae Sung Sohn, Jeeyun Lee, +14

Journal of Clinical Oncology

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

Hedy L. Kindler, Tatsuya Ioka, D. J. Richel, +14

The Lancet Oncology

Gemcitabine Versus PlaceboOncologyPancreatic CancerGastrointestinal OncologyPharmacology +5

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial

Yong Sang Hong, Byung‐Ho Nam, Kyu-pyo Kim, +6

The Lancet Oncology

Surgical OncologyRadiation TherapyGastrointestinal OncologyMedicineAdjuvant Chemotherapy +7

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study

Jianming Xu, Tae Won Kim, Lin Shen, +17

Journal of Clinical Oncology

Cancer ManagementPharmacotherapySurgeryGynecology OncologyOncology +16

Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial

Jeeyun Lee, Seung Tae Kim, Kyung Kim, +36

Cancer Discovery

Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer

Se Hoon Park, Caroline J. Breitbach, Jeeyun Lee, +13

Molecular Therapy

Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial

Yong Sang Hong, Sun Young Kim, Ji Sung Lee, +18

Journal of Clinical Oncology

Extranodal nasal type NK/T-cell Lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy

Won Seog Kim, Seung‐Sook Lee, Baek‐Yeol Ryoo, +13

European Journal of Cancer

Lymphoid NeoplasiaRisk-based StratificationImmunodeficienciesMedicineImmunology +5